Table 1 Clinical characteristics of COAD in each data set
From: Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma
Characteristics | Test series | Validation series | Entire series |
|---|---|---|---|
Gender | |||
 Male | 157/300 (52.3) | 74/141 (52.5) | 231/441 (52.4) |
 Female | 143/300 (47.7) | 67/141 (47.5) | 210/441 (47.6) |
Age(years) | |||
 ≥ 68 | 166/300 (55.3) | 71/141 (50.4) | 237/441 (53.7) |
 < 68 | 134/300 (44.7) | 70/141(49.6) | 204/441 (46.3) |
TNM stage | |||
 I | 55/290 (19.0) | 18/140 (12.9) | 73/430 (17.0) |
 II | 113/290 (39.0) | 55/140 (39.3) | 168/430 (39.1) |
 III | 82/290 (28.3) | 42/140 (30.0) | 124/430 (28.8) |
 IV | 40/290 (13.8) | 25/140 (17.9) | 65/430 (15.1) |
Race | |||
 Non-white | 47/191 (24.6) | 24/92 (26.1) | 71/283 (25.1) |
 White | 144/191 (75.4) | 68/92 (73.9) | 212/283 (74.9) |
T stage | |||
 T1 | 8/299 (2.7) | 3/141 (2.1) | 11/440 (2.5) |
 T2 | 55/299 (18.4) | 20/141 (14.3) | 74/440 (16.8) |
 T3 | 200/299 (66.9) | 100/141 (70.9) | 300/440 (68.2) |
 T4 | 36/299 (12.0) | 18/141 (12.8) | 55/440 (12.5) |
N stage | |||
 N0 | 179/300 (59.7) | 78/141 (55.3) | 257/441 (58.3) |
 N1 | 70/300 (23.3) | 34/141 (24.1) | 104/441 (23.6) |
  N2 | 51/300 (17.0) | 29/141 (20.6) | 80/441 (18.1) |
M stage | |||
 M0 | 219/259 (84.6) | 101/126 (80.2) | 320/385 (83.1) |
 M1 | 40/259 (15.4) | 25/126 (19.8) | 65/385 (16.9) |
Lymphatic invasion | |||
 No | 172/270 (63.7) | 71/129 (55.0) | 243/399 (60.9) |
 Yes | 98/270 (36.3) | 58/129 (45.0) | 156/399 (39.1) |
Microsatallite instability | |||
 No | 58/65 (89.2) | 22/26 (84.6) | 80/91 (87.9) |
 Yes | 7/65 (10.8) | 4/26(15.4) | 11/91 (12.1) |
History colon polyps | |||
 NO | 176/261 (67.4) | 76/120 (63.3) | 243/372 (65.3) |
 Yes | 85/261(32.6) | 44/120 (36.7) | 129/372 (34.7) |
Cancer status | |||
 Tumor free | 139/267 (52.1) | 58/125 (46.4) | 197/392 (50.3) |
 With tumor | 128/267 (47.9) | 67/125 (53.6) | 195/392 (49.7) |